Who is sponsoring NCT04067271?

NCT04067271 is sponsored by University of Luebeck.

What drugs are being tested in NCT04067271?

Interventions in NCT04067271: Analyze changes in intestinal microbiome.

What condition does NCT04067271 study?

NCT04067271 studies ICU Patients.

Is NCT04067271 still recruiting?

NCT04067271 is currently status unknown. Last updated 18 May 2022.

Last reviewed 2022-05-18 · How we verify

NCT04067271: LUERIC-M

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

LUEbeck Registry of Intensive Care Patients - Characterization of the Patients Intestinal MICROBIOME

Status unknown Last updated 18 May 2022

What this trial tests

trial testing Analyze changes in intestinal microbiome in ICU Patients in 200 participants. Status unknown.

Timeline

18 March 2019

Primary endpoint
18 March 2024

18 March 2024

Quick facts

Lead sponsor	University of Luebeck
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	200
Start date	18 March 2019
Primary completion	18 March 2024
Estimated completion	18 March 2024
Sites	1 location across Germany

Drugs / interventions tested

Analyze changes in intestinal microbiome

Conditions studied

ICU Patients — all drugs for ICU Patients →

Sponsor

University of Luebeck

Who can join

18 and older, any sex, with ICU Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the current study is to analyze the effects of ICU-care on changes in microbiome and the influence of intestinal microbiome changes on short-term and long-term morbidity and mortality of ICU patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for ICU Patients

Currently open trials in the same condition.

NCT07149246 — The Effect of a 6-month Dietitian-tailored Nutrition Intervention to Patients With Critical Illness (DETAIL) · NA · recruiting

Other University of Luebeck trials

Trials by the same sponsor.

NCT06598280 — Same-Day Discharge Versus Overnight Stay Following Pulmonary Vein Isolation for Atrial Fibrillation · NA · recruiting
NCT06493994 — Myval TransAXillary Transcatheter Aortic Valve Replacement Multicenter Clinical Registry · recruiting
NCT05846412 — Treatment of Functional Mitral Regurgitation in Patients With Atrial Fibrillation · NA · unknown
NCT05710822 — QDOT Based PVI for Atrial Fibrillation Treatment - The peQasus Study · unknown
NCT05563142 — Venous Vascular Closure System Versus Manual Compression Following Single Shot Device AF Ablation · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04067271 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Luebeck
Last refreshed: 18 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04067271.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing